Nextrials Launches Prism 3.0
San Ramon, CA-September 30, 2009
Nextrials, Inc.
, has upgraded its electronic data capture and clinical trial management platform, Prism. In addition to its new user interface, Prism now offers expanded functionality and interoperability with electronic health records from multiple vendors.
Prism users will see differences to its start page, where researchers can now evaluate project data from multiple studies organized into modules that can be collapsed and expanded for review. The “at a glance” statistics roll-up bar is intended to provide users with fast facts, such as enrollment status and data quality metrics. And with Prism’s newly streamlined structure, pop-up windows have been reduced in favor of intuitive layers within the browser.
A significant change to Prism is its interoperability with data platforms more traditionally found within the healthcare environment for creating and managing electronic medical records. This gives life science companies many more options for implementing studies using patients and sites. Also, major incentives included in the American Recovery and Reinvestment Act (ARRA) will further promote the adoption of electronic medical records.
Nextrials expanded Prism’s report generation functionality earlier in the year to give users more powerful data mining capabilities. This ad hoc reporting feature has been further enhanced so that customers can now share reports with others, more easily monitor study progress and even drill down to analyze underlying data.
Prism 3.0 will continue to support mobile access to data via the Apple iPhone. Nextrials expects Prism 3.0 to be in general availability before the end of the year. However, attendees at the 2009 Society for Clinical Data Management Annual Conference, being held at the Westin Seattle (WA) Hotel October 4-6, can get a first look at Nextrials’ Prism 3.0 in booth #301 and #303.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
